Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition.
Menopausal hormone therapy (HT) may influence colorectal cancer risk. A total of 136,275 postmenopausal women from the European Prospective Investigation into Cancer and Nutrition were followed for an average of 9 years, during which time 1,186 colorectal cancers were diagnosed. Hazard ratios (HR) a...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2011
|
| _version_ | 1826297331729825792 |
|---|---|
| author | Tsilidis, K Allen, N Key, T Sanjoaquin, M Bakken, K Berrino, F Fournier, A Lund, E Overvad, K Olsen, A Tjønneland, A Byrnes, G Chajes, V Rinaldi, S Boutron-Ruault, M Clavel-Chapelon, F Chang-Claude, J Kaaks, R Bergmann, M Boeing, H Koumantaki, Y Palli, D Pala, V Panico, S Tumino, R |
| author_facet | Tsilidis, K Allen, N Key, T Sanjoaquin, M Bakken, K Berrino, F Fournier, A Lund, E Overvad, K Olsen, A Tjønneland, A Byrnes, G Chajes, V Rinaldi, S Boutron-Ruault, M Clavel-Chapelon, F Chang-Claude, J Kaaks, R Bergmann, M Boeing, H Koumantaki, Y Palli, D Pala, V Panico, S Tumino, R |
| author_sort | Tsilidis, K |
| collection | OXFORD |
| description | Menopausal hormone therapy (HT) may influence colorectal cancer risk. A total of 136,275 postmenopausal women from the European Prospective Investigation into Cancer and Nutrition were followed for an average of 9 years, during which time 1,186 colorectal cancers were diagnosed. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using Cox proportional hazards models stratified by center and age, and adjusted for body mass index, smoking, diabetes, physical activity and alcohol consumption. Compared to never use of HT at study enrollment, current use of estrogen-only (HR, 1.02; 95% CI, 0.79-1.31) or estrogen plus progestin (HR, 0.94; 95% CI, 0.77-1.14) was not significantly associated with the risk of colorectal cancer, and these associations did not vary by recency, duration, route of administration, regimen or specific constituent of HT. Our results show no significant association of estrogen-only or estrogen plus progestin therapy with colorectal cancer risk. |
| first_indexed | 2024-03-07T04:29:58Z |
| format | Journal article |
| id | oxford-uuid:cdf6ca91-f3dc-4812-98b7-732995360b96 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:29:58Z |
| publishDate | 2011 |
| record_format | dspace |
| spelling | oxford-uuid:cdf6ca91-f3dc-4812-98b7-732995360b962022-03-27T07:32:34ZMenopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:cdf6ca91-f3dc-4812-98b7-732995360b96EnglishSymplectic Elements at Oxford2011Tsilidis, KAllen, NKey, TSanjoaquin, MBakken, KBerrino, FFournier, ALund, EOvervad, KOlsen, ATjønneland, AByrnes, GChajes, VRinaldi, SBoutron-Ruault, MClavel-Chapelon, FChang-Claude, JKaaks, RBergmann, MBoeing, HKoumantaki, YPalli, DPala, VPanico, STumino, RMenopausal hormone therapy (HT) may influence colorectal cancer risk. A total of 136,275 postmenopausal women from the European Prospective Investigation into Cancer and Nutrition were followed for an average of 9 years, during which time 1,186 colorectal cancers were diagnosed. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using Cox proportional hazards models stratified by center and age, and adjusted for body mass index, smoking, diabetes, physical activity and alcohol consumption. Compared to never use of HT at study enrollment, current use of estrogen-only (HR, 1.02; 95% CI, 0.79-1.31) or estrogen plus progestin (HR, 0.94; 95% CI, 0.77-1.14) was not significantly associated with the risk of colorectal cancer, and these associations did not vary by recency, duration, route of administration, regimen or specific constituent of HT. Our results show no significant association of estrogen-only or estrogen plus progestin therapy with colorectal cancer risk. |
| spellingShingle | Tsilidis, K Allen, N Key, T Sanjoaquin, M Bakken, K Berrino, F Fournier, A Lund, E Overvad, K Olsen, A Tjønneland, A Byrnes, G Chajes, V Rinaldi, S Boutron-Ruault, M Clavel-Chapelon, F Chang-Claude, J Kaaks, R Bergmann, M Boeing, H Koumantaki, Y Palli, D Pala, V Panico, S Tumino, R Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. |
| title | Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. |
| title_full | Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. |
| title_fullStr | Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. |
| title_full_unstemmed | Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. |
| title_short | Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. |
| title_sort | menopausal hormone therapy and risk of colorectal cancer in the european prospective investigation into cancer and nutrition |
| work_keys_str_mv | AT tsilidisk menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT allenn menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT keyt menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT sanjoaquinm menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT bakkenk menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT berrinof menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT fourniera menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT lunde menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT overvadk menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT olsena menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT tjønnelanda menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT byrnesg menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT chajesv menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT rinaldis menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT boutronruaultm menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT clavelchapelonf menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT changclaudej menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT kaaksr menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT bergmannm menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT boeingh menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT koumantakiy menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT pallid menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT palav menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT panicos menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition AT tuminor menopausalhormonetherapyandriskofcolorectalcancerintheeuropeanprospectiveinvestigationintocancerandnutrition |